tiprankstipranks
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics (ALLR) Financial Statements

372 Followers

Allarity Therapeutics Financial Overview

Allarity Therapeutics's market cap is currently $19.77M. The company's EPS TTM is $-0.19; its P/E ratio is -1.15; Allarity Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 320.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 320.00K$ 0.00$ -37.00K$ -120.00K$ -106.00K
Operating Income$ -12.61M$ -27.24M$ -17.13M$ -34.46M$ -26.56M
EBITDA$ -11.05M$ -24.23M$ -11.28M$ -17.30M$ -25.77M
Net Income$ -11.23M$ -24.52M$ -11.90M$ -16.06M$ -26.65M
Balance Sheet
Cash & Short-Term Investments$ 14.69M$ 19.53M$ 166.00K$ 2.03M$ 19.91M
Total Assets$ 18.26M$ 22.65M$ 11.86M$ 14.54M$ 49.63M
Total Debt$ 1.40M$ 1.35M$ 1.30M$ 3.73M$ 1.09M
Net Debt$ -13.29M$ -18.18M$ 1.13M$ 1.71M$ -18.47M
Total Liabilities$ 8.43M$ 10.84M$ 14.61M$ 12.65M$ 30.85M
Stockholders' Equity$ 9.83M$ 11.81M$ -2.75M$ 1.89M$ 18.78M
Cash Flow
Free Cash Flow$ -14.83M$ -17.65M$ -12.74M$ -16.84M$ -15.05M
Operating Cash Flow$ -14.82M$ -17.35M$ -12.74M$ -16.82M$ -15.05M
Investing Cash Flow$ -8.00K$ -298.00K$ 0.00$ 791.00K$ 1.00M
Financing Cash Flow$ 10.65M$ 36.79M$ 10.99M$ -1.31M$ 33.82M
Currency in USD

Allarity Therapeutics Earnings and Revenue History

Allarity Therapeutics Debt to Assets

Allarity Therapeutics Cash Flow

Allarity Therapeutics Forecast EPS vs Actual EPS